Although the roles/functions of the GNAS mutations in IPMN or PDAC have not been elucidated, these mutations may be associated more with tumour initiation than with tumour progression because the mutation has also been observed in low-grade tumours [10], [12]. The gene discussed is GNAS; the disease is pancreatic intraductal papillary-mucinous neoplasm.